CompoAtlas

Slim Tech Formula

Slim Tech Formula, licence 80056216: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Canadian Phytopharmaceuticals Corporation
NPN or DIN-HM
80056216
Status
Active licence
Licence date
3 December 2014
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Crataegus pinnatifida

Source : Crataegus pinnatifida, fruit

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 100 mg

10.0 mgNot calculated
Vinaigre de cidre

Source : Groupe de vinaigre de cidre - fruit

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 2.5 mg

500.0 mgNot calculated

Non-medicinal ingredients

Maltodextrine, Extrait de pectine de Pyrus malus (pomme), Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19.0 Année(s)minimum: 1.0 Capsule ; maximum: 2.0 Capsule1.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

N/ATo be used with a program of reduced intake of dietary calories and increased physical activity (if possible) to help in weight management. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80056216

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line